92 related articles for article (PubMed ID: 30111862)
1. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas.
Masuelli L; Di Stefano E; Fantini M; Mattera R; Benvenuto M; Marzocchella L; Sacchetti P; Focaccetti C; Bernardini R; Tresoldi I; Izzi V; Mattei M; Frajese GV; Lista F; Modesti A; Bei R
Oncotarget; 2014 Nov; 5(21):10745-62. PubMed ID: 25296980
[TBL] [Abstract][Full Text] [Related]
2. GZ17-6.02 kills PDX isolates of uveal melanoma.
Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress.
Martinez-Ruiz L; Florido J; Rodriguez-Santana C; López-Rodríguez A; Guerra-Librero A; Fernández-Gil BI; García-Tárraga P; Garcia-Verdugo JM; Oppel F; Sudhoff H; Sánchez-Porras D; Ten-Steve A; Fernández-Martínez J; González-García P; Rusanova I; Acuña-Castroviejo D; Carriel V; Escames G
Biomed Pharmacother; 2023 Nov; 167():115518. PubMed ID: 37717534
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells.
Hu S; Xu Y; Meng L; Huang L; Sun H
Exp Ther Med; 2018 Aug; 16(2):1266-1272. PubMed ID: 30116377
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers.
Li Y; Domina A; Lim G; Chang T; Zhang T
Future Oncol; 2018 Oct; 14(23):2353-2360. PubMed ID: 30139269
[TBL] [Abstract][Full Text] [Related]
6. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydrocurcumin, a major metabolite of curcumin, ameliorates allergic airway inflammation by attenuating Th2 response and suppressing the IL-4Rα-Jak1-STAT6 and Jagged1/Jagged2 -Notch1/Notch2 pathways in asthmatic mice.
Chen BL; Chen YQ; Ma BH; Yu SF; Li LY; Zeng QX; Zhou YT; Wu YF; Liu WL; Wan JB; Yang Y; Li CW
Clin Exp Allergy; 2018 Nov; 48(11):1494-1508. PubMed ID: 30137697
[TBL] [Abstract][Full Text] [Related]
8. The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.
Lin SC; Cheifetz AS
Gastroenterol Hepatol (N Y); 2018 Jul; 14(7):415-425. PubMed ID: 30166957
[TBL] [Abstract][Full Text] [Related]
9. GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells.
Booth L; Roberts JL; West C; Dent P
Oncotarget; 2024 Mar; 15():159-174. PubMed ID: 38441437
[TBL] [Abstract][Full Text] [Related]
10. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.
Booth MR; Booth L; Roberts JL; West C; Dent P
Oncotarget; 2024 Feb; 15():124-133. PubMed ID: 38329728
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA; Reddy SV; Choi J; Braun G; McKeel J; Lu W; Yossef SM; Ma EZ; West CE; Kwatra SG; Kwatra MM
Sci Rep; 2024 Jan; 14(1):1955. PubMed ID: 38263212
[TBL] [Abstract][Full Text] [Related]
12. Topical GZ21T Inhibits the Growth of Actinic Keratoses in a UVB-Induced Model of Skin Carcinogenesis.
Bordeaux ZA; Choi J; Braun G; Davis C; Marani M; Lee K; Samuel C; Adams J; Windom R; Pollizzi A; Kambala A; Cornman H; Reddy SV; Lu W; Oladipo OO; Alphonse MP; West CE; Kwatra SG; Kwatra MM
JID Innov; 2023 Jul; 3(4):100206. PubMed ID: 37533581
[TBL] [Abstract][Full Text] [Related]
13. Combined treatments with AZD5363, AZD8542, curcumin or resveratrol induce death of human glioblastoma cells by suppressing the PI3K/AKT and SHH signaling pathways.
Mejía-Rodríguez R; Romero-Trejo D; González RO; Segovia J
Biochem Biophys Rep; 2023 Mar; 33():101430. PubMed ID: 36714540
[TBL] [Abstract][Full Text] [Related]
14. Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma.
Standing D; Arnold L; Dandawate P; Ottemann B; Snyder V; Ponnurangam S; Sayed A; Subramaniam D; Srinivasan P; Choudhury S; New J; Kwatra D; Ramamoorthy P; Roy BC; Shadoin M; Al-Rajabi R; O'Neil M; Gunewardena S; Ashcraft J; Umar S; Weir SJ; Tawfik O; Padhye SB; Biersack B; Anant S; Thomas SM
Mol Carcinog; 2023 Feb; 62(2):145-159. PubMed ID: 36218231
[TBL] [Abstract][Full Text] [Related]
15. GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.
Choi J; Bordeaux ZA; McKeel J; Nanni C; Sutaria N; Braun G; Davis C; Miller MN; Alphonse MP; Kwatra SG; West CE; Kwatra MM
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456993
[TBL] [Abstract][Full Text] [Related]
16. Reaction between harmaline and vanillin to produce dimeric scaffoldsthat exhibit anti-proliferative activity.
Birar VC; Zaid G; Blagg BSJ
Tetrahedron Lett; 2021 Jun; 73():. PubMed ID: 34672489
[TBL] [Abstract][Full Text] [Related]
17. GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins.
Booth L; West C; Moore RP; Von Hoff D; Dent P
Front Oncol; 2021; 11():711043. PubMed ID: 34490108
[TBL] [Abstract][Full Text] [Related]
18. GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling.
Booth L; West C; Hoff DV; Dent P
Front Oncol; 2020; 10():1331. PubMed ID: 32983965
[TBL] [Abstract][Full Text] [Related]
19. Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Vishwakarma V; New J; Kumar D; Snyder V; Arnold L; Nissen E; Hu Q; Cheng N; Miller D; Thomas AR; Shnayder Y; Kakarala K; Tsue TT; Girod DA; Thomas SM
Sci Rep; 2018 Aug; 8(1):12163. PubMed ID: 30111862
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
